Pharmacotherapy of primary CNS lymphoma

Author： Park Deric Minwoo Abrey Lauren E

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.1, 2002-01, pp. : 39-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy for Primary CNS Lymphoma: Progress Beyond Methotrexate?

By Graber Jerome J. Omuro Antonio

CNS Drugs, Vol. 25, Iss. 6, 2011-06 ,pp. : 447-457

Adis International

Access to resources Recommend Favorite

Mycophenolate mofetil: Primary CNS lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1137, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Azathioprine: Primary CNS lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders

By Rossi Daniela Martorana Francesca Brambilla Liliana

CNS Drugs, Vol. 25, Iss. 8, 2011-08 ,pp. : 641-658

Adis International

Access to resources Recommend Favorite

Antineoplastics/immunosuppressants: EBV-associated primary CNS lymphoma, and malignant melanoma, in elderly patients: 4 case reports

Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite